Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine

Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine

Over the last several years, the recommended use of the live-attenuated influenza vaccine (LAIV) for children has evolved in the United States (US) in response to evidence of a potential decrease in LAIV effectiveness based on post-market monitoring. These issues were not observed in Canada or elsew...

Full description

Bibliographic Details
Main Authors: Linlu Zhao, Kelsey Young, Althea House, Rob Stirling, Matthew Tunis
Format: Article
Language:English
Published: Public Health Agency of Canada 2021-05-01
Series:Canada Communicable Disease Report
Subjects:
influenza
laiv
nasal spray
post-market surveillance
vaccine effectiveness
Online Access:https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/national-advisory-committee-immunization-recommendations-post-market-vaccine-live-attenuated-influenza-vaccine.html

Internet

https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/national-advisory-committee-immunization-recommendations-post-market-vaccine-live-attenuated-influenza-vaccine.html

Similar Items